Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million
Regeneron to Buy 23andMe Out of Bankruptcy for $256 Million · The Wall Street Journal

In This Article:

The move raises privacy concerns as the drugmaker takes control of the genetic data of millions of clients of the once-sizzling DNA-testing startup.